Analysis of generic drug quality and market penetration in Poland

An investigative report examines the efficacy and safety standards of generic pharmaceuticals, which constitute 80% of the Polish drug market. The piece highlights concerns regarding manufacturing oversight and quality control, drawing on international investigative findings to question the equivalence of generics to original branded medications.